Colorado Blood Cancer Institute ( Site 2726) — Denver, Colorado

Colorado Blood Cancer Institute ( Site 2726) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute ( Site 2726) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute ( Site 2726)?

Colorado Blood Cancer Institute ( Site 2726) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute ( Site 2726) conducted?

Colorado Blood Cancer Institute ( Site 2726) has 1 clinical trials on record, with 1 currently active. Their work covers Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma.

Is Colorado Blood Cancer Institute ( Site 2726) accredited by Crixeo Health?

Colorado Blood Cancer Institute ( Site 2726) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute ( Site 2726)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.